Multidisciplinary management of hepatocellular carcinoma

Recent Results in Cancer Research

Volumn 190, Issue , 2013, Pages 247-259

  Kaseb, Ahmed O ^a   Abaza, Yasmin M ^a   Roses, Robert E ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SORAFENIB;

ARTICLE; ARTIFICIAL EMBOLISM; CANCER PROGNOSIS; CANCER STAGING; HEALTH CARE MANAGEMENT; HEPATOGRAPHY; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER INJURY; LIVER TRANSPLANTATION; MEDICAL SPECIALIST; PATIENT ASSESSMENT; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT PLANNING;

CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; DISEASE MANAGEMENT; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 84868329010     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-16037-0_16     Document Type: Article

References (51)

1. Parkin DM, Bray F, Ferlay J et al (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156 (Pubitemid 32911406)
2. Vauthey JN, Lauwers GY, Esnaola NF et al (2002) Simplified staging for hepatocellular carcinoma. J Clin Oncol 20:1527-1536 (Pubitemid 34260532)
3. Takayasu K, Arii S, Ikai I et al (2006) Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131:461-469 (Pubitemid 44142456)
4. Bedossa P, Dargere D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38:1449-1457 (Pubitemid 37466971)
5. Ishizawa T, Hasegawa K, Aoki T et al (2008) Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134:1908-1916 (Pubitemid 351783260)
6. Teh SH, Christein J, Donohue J et al (2005) Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: model of end-stage liver disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 9:1207-1215 (Pubitemid 41751112)
7. Cucchetti A, Ercolani G, Vivarelli M et al (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12:966-971 (Pubitemid 43960373)
8. Capussotti L, Ferrero A, Vigano L et al (2006) Portal hypertension: contraindication to liver surgery? World J Surg 30:992-999 (Pubitemid 43824409)
9. Iannaccone R, Laghi A, Catalano C et al (2005) Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology 234:460-467 (Pubitemid 40139917)
10. Laghi A, Iannaccone R, Rossi P et al (2003) Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis. Radiology 226: 543-549 (Pubitemid 36313447)
11. Rode A, Bancel B, Douek P et al (2001) Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 25:327-336 (Pubitemid 32440782)
12. Burrel M, Llovet JM, Ayuso C et al (2003) MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 38: 1034-1042 (Pubitemid 37221687)
13. Kim HJ, Kim KW, Byun JH et al (2006) Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. AJR Am J Roentgenol 186:1059-1066
14. Frericks BB, Loddenkemper C, Huppertz A et al (2009) Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. AJR Am J Roentgenol 193:1053-1060
15. Hammerstingl R, Huppertz A, Breuer J et al (2008) Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 18:457-467 (Pubitemid 351248177)
16. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet, 362:1907-1917 (Pubitemid 37518510)
17. Jung G, Breuer J, Poll LW et al (2006) Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA. Acta Radiol 47:15-23 (Pubitemid 43177525)
18. Bhartia B, Ward J, Guthrie JA et al (2003) Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR Am J Roentgenol 180:577-584 (Pubitemid 36237194)
19. Lee VS, Hecht EM, Taouli B et al (2007) Body and cardiovascular MR imaging at 3.0 T. Radiology 244:692-705 (Pubitemid 47292080)
20. Mannelli L, Kim S, Hajdu CH et al (2009) Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. AJR Am J Roentgenol 193:1044-1052
21. Huwart L, Sempoux C, Vicaut E et al (2008) Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135:32-40 (Pubitemid 351899024)
22. Hagiwara M, Rusinek H, Lee VS et al (2008) Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging - initial experience. Radiology 246:926-934
23. Forner A, Vilana R, Ayuso C et al (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47:97-104 (Pubitemid 351171046)
24. DuBay D, Sandroussi C, Sandhu L et al (2011) Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion. Ann Surg 253:166-172
25. Vauthey JN, Dixon E, Abdalla EK et al (2010) Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 12:289-299
26. Llovet JM, Di Bisceglie AM, Bruix J et al (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100:698-711
27. Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329-338
28. Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378-390
29. Cillo U, Bassanello M, Vitale A et al (2004) The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol 40:124-131 (Pubitemid 38064721)
30. Cillo U, Vitale A, Grigoletto F et al (2006) Prospective validation of the Barcelona clinic liver cancer staging system. J Hepatol 44:723-731
31. Jonas S, Al-Abadi H, Benckert C et al (2009) Prognostic significance of the DNA-index in liver transplantation for hepatocellular carcinoma in cirrhosis. Ann Surg 250:1008-1013
32. Poon RT, Lau C, Pang R et al (2007) High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies. Ann Surg Oncol 14:1835-1845 (Pubitemid 46870942)
33. Kaseb AO, Abbruzzese JL, Vauthey JN et al (2011) I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score. Oncology 80:373-381
34. Prasad KR, Young RS, Burra P et al (2011) Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. Liver Transpl 17(Suppl 2):S81-89
35. Belghiti J (2009) Resection and liver transplantation for HCC. J Gastroenterol 44(Suppl 19):132-135
36. Cherqui D, Laurent A, Mocellin N et al (2009) Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg 250:738-746
37. Otsuka Y, Duffy JP, Saab S et al (2007) Postresection hepatic failure: successful treatment with liver transplantation. Liver Transpl 13:672-679 (Pubitemid 46796538)
38. Scatton O, Zalinski S, Terris B et al (2008) Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation. Liver Transpl 14:779-788 (Pubitemid 351899426)
39. Kulik LM, Atassi B, van Holsbeeck L et al (2006) Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 94:572-586 (Pubitemid 44851918)
40. Lewandowski RJ, Kulik LM, Riaz A et al (2009) A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 9:1920-1928
41. Llovet JM, Real MI, Montana X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734-1739 (Pubitemid 34607087)
42. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. N Engl J Med (1995) 332:1256-1261
43. Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164-1171 (Pubitemid 34454013)
44. Schwarz RE, Abou-Alfa GK, Geschwind JF et al (2010) Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement. HPB (Oxford) 12:313-320
45. Krishnan S, Dawson LA, Seong J et al (2008) Radiotherapy for hepatocellular carcinoma: an overview. Ann Surg Oncol 15:1015-1024
46. Hawkins MA, Dawson LA (2006) Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer 106:1653-1663
47. Chiba T, Tokuuye K, Matsuzaki Y et al (2005) Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res 11:3799-3805 (Pubitemid 40685599)
48. Kawashima M, Furuse J, Nishio T et al (2005) Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol 23:1839-1846 (Pubitemid 46211361)
49. Yasuda S, Ito H, Yoshikawa M et al (1999) Radiotherapy for large hepatocellular carcinoma combined with transcatheter arterial embolization and percutaneous ethanol injection therapy. Int J Oncol 15:467-473
50. Seong J, Keum KC, Han KH et al (1999) Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 43:393-397 (Pubitemid 29091482)
51. Guo WJ, Yu EX (2000) Evaluation of combined therapy with chemoembolization and irradiation for large hepatocellular carcinoma. Br J Radiol 73:1091-1097